He subsequently went on to investigate the potential neuro-protective effects of the feeding hormone leptin in Alzheimer's disease at the University of Dundee, Scotland. Here he worked on the longitudinal characterisation of genetically faithful parkinsonian models in an attempt to isolate changes in synaptic function over time in disease. Using human iPSCs as a model and with a focus of electrophysiology and calcium imaging as tools, he identified robust phenotypes relating to synaptic function and energy. In 2020, Dr Beccano-Kelly won the prestigious Future Leader Fellowship allowing him to carry out his work on early synaptic health in Parkinson’s disease as a Group Leader based at UK DRI at Cardiff from February 2021.